JSP191 Antibody Targeting Conditioning in SCID Patients

NCT02963064 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
23
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor Decision - terminated due to changes in company priorities and not related to safety concerns.

Conditions

Interventions

Sponsor

Jasper Therapeutics, Inc.